Platform of the neurodegenerative research community, fast peer review
Neurodegenerative Diseases is a multidisciplinary journal dedicated to publishing and discussing advances in research on all aspects of neurodegenerative diseases. The journal focuses on Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and Huntington disease but also welcomes articles on related neurological and psychiatric disorders. It has a particular emphasis on the interplay between vascular pathology, neuroinflammatory change, and the progression of neurodegenerative disease. In addition to clinical and basic science studies, brief methodological papers are welcome in the emerging fields of statistical genetics, clinical and preclinical neuroimaging, novel algorithms of biomedical image computing, and other approaches elucidating mechanisms of neurodegenerative disease. Neurodegenerative Diseases accepts high-quality papers in the form of brief reports, research articles, and review articles from a broad spectrum of scientific research areas ranging from neuroscience and genetics to clinical and preclinical neuroimaging and biomarker studies, molecular and cell biology, as well as pharmacology. All articles undergo rigorous scientific as well as statistical/bioinformatic peer review to ensure excellence. The journal provides fast peer review and provides opportunities for open-access publication.
About this Journal
Calls for Papers
Anti-amyloid Drugs: A Therapeutical Revolution in Alzheimer’s Disease
Extended Submission Deadline: April 30, 2024
Sex and Gender in Neurodegenerative Diseases
Submission Deadline: September 30, 2024
|Impact Factor: 3.0
|Acceptance Rate: 29%
|Time to first decision: 35 days
The Neurodegenerative Diseases Transformative Journal model supports authors and organizations in making a sustainable transition to Open Access, while enabling authors' publishing preferences.
For more information, refer to the journal's guidelines.
News & Highlights
Neurodegenerative Diseases is Member of NPRC
The Neuroscience Peer Review Consortium (NPRC) is an alliance of neuroscience journals that share manuscript reviews with other NPRC members at the author's request. The NPRC system facilitates fast-track review and publication of neuroscience research, and reduces the burden on peer reviewers.
On the 1st of August 2023, a new cycle initiated for Neurodegenerative Diseases. We welcome Prof. Gilles Allali, head of the Leenaards Memory Centre – CHUV Lausanne, Switzerland, as the new Editor-in-Chief of Neurodegenerative Diseases. Our heartfelt thanks to Prof. Unschuld who led the Journal as Editor-in-Chief for the past 5 and a half years.
Read the Publisher's Note marking this change in leadership: New editorship of Neurodegenerative Diseases
And Prof. Allali’s editorial: A Pivotal Time
Check Out Our Article Collections
Issues & Articles
Accepted and fully citable articles not yet assigned to an issue.